{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10976580", "DateCompleted": {"Year": "2001", "Month": "01", "Day": "04"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0253-6269", "JournalIssue": {"Volume": "23", "Issue": "4", "PubDate": {"Year": "2000", "Month": "Aug"}}, "Title": "Archives of pharmacal research", "ISOAbbreviation": "Arch Pharm Res"}, "ArticleTitle": "Activity of crude extract of Rubus crataegifolius roots as a potent apoptosis inducer and DNA topoisomerase I inhibitor.", "Pagination": {"StartPage": "338", "EndPage": "343", "MedlinePgn": "338-43"}, "Abstract": {"AbstractText": ["The effects of methanol extract of Rubus crategifolius roots and its solvent fractions were investigated on the proliferation of MCF-7 human breast carcinoma cells. The methanol extract inhibited the proliferation of MCF-7 cells in a concentration dependent manner. Moreover, their methanol soluble (W-M) fraction had the greatest inhibitory effect on the growth of MCF-7 cells. To evaluate whether the W-M fraction affects on the cell cycle of MCF-7 cells, cells treated with this fraction were analyzed with flow cytometry. The W-M fraction increased G0/G1 phase after 24 h-treatment and induced apoptosis after 48 h-treatment. The hallmark of apoptosis, DNA fragmentation, also appeared by W-M fraction after 48 h-treatment. Furthermore, the methanol extract and its W-M fraction inhibited the activity of the topoisomerase I enzyme in the relaxation assay. From these results, their W-M fraction as well as methanol extract of R. crategifolius roots are necessary for further studies as a potent inhibitor of the growth of cancer cells."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Korea."}], "Identifier": [], "LastName": "Lee", "ForeName": "J H", "Initials": "JH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ham", "ForeName": "Y A", "Initials": "YA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Choi", "ForeName": "S H", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Im", "ForeName": "E O", "Initials": "EO"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jung", "ForeName": "J H", "Initials": "JH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Im", "ForeName": "K S", "Initials": "KS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "D K", "Initials": "DK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xu", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "M W", "Initials": "MW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "N D", "Initials": "ND"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "Arch Pharm Res", "NlmUniqueID": "8000036", "ISSNLinking": "0253-6269"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Topoisomerase I Inhibitors"}, {"RegistryNumber": "7673326042", "NameOfSubstance": "Irinotecan"}, {"RegistryNumber": "XT3Z54Z28A", "NameOfSubstance": "Camptothecin"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Camptothecin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Fragmentation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Irinotecan"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Topoisomerase I Inhibitors"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "9", "Day": "8", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "2", "Day": "28", "Hour": "10", "Minute": "1"}, {"Year": "2000", "Month": "9", "Day": "8", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10976580", "10.1007/BF02975444"]}}], "PubmedBookArticle": []}